Medication-Assisted Treatment for Youth With Substance Use Disorders
Status:
Completed
Trial end date:
2018-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this open-label pilot study is to determine the tolerability and applicability
of outpatient long-acting injectable naltrexone (Vivitrol) treatment in individuals age 16-25
("older youth") with opioid use disorder. Outpatient treatment will consist of a 7-day
outpatient detoxification / naltrexone induction procedure followed by 8-weeks of treatment
with Vivitrol.